PriceSensitive

HYTN (CSE:HYTN) signs agreement with Rose to initiate sales of cannabis products in Quebec

Cannabis
CSE:HYTN
24 October 2022 13:30 (EDT)

HYTN Innovations Inc.

HYTN Innovations’ (HYTN) subsidiary, HYTN Cannabis, has signed a sales, distribution and marketing agreement with Rose LifeScience Inc.

The agreement allows HYTN to sell its products, through Rose, to la Société québécoise du cannabis (the SQDC). It supports the company’s goal of delivering its consistent, natural and delicious cannabis products featuring Elevation Technology to every province and territory in Canada.

Rose is a leading supplier of cannabis products in Quebec. It ensures that consumers benefit from the responsible production, sale, and consumption of cannabis in Québec and across Canada.

HYTN notes that it has achieved vendor qualification in all Canadian markets. However, Quebec is a unique market that requires hands-on experience and on-the-ground presence.

Jason Broome, Chief Operating Officer of HYTN, commented on the news.

“Quebec is a critical market for HYTN’s cannabis beverages. Our formulations team has created unique products specifically for Quebec. We are proud that HYTN has focused on Quebec’s needs by delivering the only sugar-free maximum allowable dose, rapid onset beverage available to consumers in the province. It is a testament to our formulation, quality and operations teams that we were able to quickly scale from bench top to brite tank to meet demand.”

As per the agreement, all revenue from orders of HYTN’s cannabis products will flow from the SQDC through Rose to HYTN. The company will then pay Rose a commission for their services. 

HYTN formulates, manufactures, markets, and sells premium cannabis goods.

HYTN Innovations Inc. (HYTN) opened trading at C$0.04 per share.


Related News